Nova Eye Medical Limited (ASX:EYE)
Australia flag Australia · Delayed Price · Currency is AUD
0.1220
-0.0030 (-2.40%)
May 18, 2026, 3:01 PM AEST

Nova Eye Medical Company Description

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma.

The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration.

It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020.

Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

Nova Eye Medical Limited
Nova Eye Medical logo
CountryAustralia
Founded1970
IndustryMedical Devices
SectorHealthcare
CEOThomas Spurling

Contact Details

Address:
107 Rundle Street
Kent Town, SA SA
Australia
Phone61 8 8362 0193

Stock Details

Ticker SymbolEYE
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000094252
SIC Code3845

Key Executives

NamePosition
Victor PrevinFounder and Chairman
Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D.MD and Executive Director
Michael SouthardExecutive Director
Kimberley MenziesChief Financial Officer
Mark FlynnInvestor Relations
Kate HuntChief Commercial Officer
Joe BankovichPresident of Global Sales
Joaquin V. WolffPresident of Ellex iTrack
Simon Jeremy Newton Gray BEc, C.A.Company Secretary
Jordan PossinghamFinancial Controller